Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Cheddar Morning News Briefings of April 25th
Cheddar Morning News Briefings
Morning Alexa Flash Briefings of April 25th
Morning Alexa Flash Briefings
Appeals Court Upholds Apple's Control of iPhone App Store
An appeals court has upheld Apple’s exclusive control over the distribution of iPhone apps.
Stretching Your Dollar: How to Decide Whether to Hire a Financial Planner
Haley Sacks, founder and CEO of Finance Is Cool, joined Cheddar News to provide tips on when hiring a financial planner is needed. "They will help you figure out exactly how to maximize your personal situation," she said. "They're going to think about your long-term plans, consider your goals and incorporate all of that into the structure that they create for you."
The Day Ahead: Major Earnings Update, State of Housing Market & Microsoft Activision Deal
The Day Ahead: Major Earning Update, State of Housing Market & Microsoft Activision Deal
Ohio Plane Fire Puts Renewed Focus on Recurring Bird Strikes
A bird strike sparked an engine fire on a plane shortly after takeoff from an Ohio airport on Sunday.
Analyst Discusses Mixed Market Trading With Earnings, Fed Meeting on Tap
Scott Wren, senior global market strategist with Wells Fargo Investment Institute, joined Cheddar News to discuss Monday's market trading as earnings continue to trickle in and ahead of a Federal Reserve meeting next week.
Disney Starts 2nd Round of Layoffs Across Parks, ESPN
The Walt Disney Co. will be laying off several thousand employees this week, a second round of cuts that’s part of a previously announced plan to eliminate 7,000 jobs this year.
Nissan Americas Chair on Company's Strategy, EV Investments
Nissan Americas Chair Jeremie Papin spoke with Cheddar News and outlined the company's strategy, specifically its future in the electric vehicle market. "We foresee potentially 40% of our sales in 2030 being EVs," he said.
